CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Capex Y/Y Annual
Lifeloc Technologies Inc   (LCTC)
Other Ticker:  
 
 

LCTC's Capital Expenditures Growth by Quarter and Year

Lifeloc Technologies Inc 's Capital Expenditures results by quarter and year

 



LCTC Capital Expenditures (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
4th Quarter December - 0.00 0.02 0.20
3rd Quarter September - 0.01 0.16 0.01
2nd Quarter June - 0.01 0.03 0.06
1st Quarter March 0.08 0.00 0.01 0.00
FY   0.08 0.02 0.22 0.27

LCTCs Annual Capital Expenditures
Lifeloc Technologies Inc 's Capital Expenditures in the fiscal year 2023 $ 0.01 millions
Lifeloc Technologies Inc 's Capital Expenditures in the fiscal year 2022 $ 0.00 millions
Lifeloc Technologies Inc 's Capital Expenditures in the fiscal year 2021 $ 0.27 millions
Lifeloc Technologies Inc 's Capital Expenditures in the fiscal year 2020 $ 0.05 millions
Lifeloc Technologies Inc 's Capital Expenditures in the fiscal year 2019 $ 0.26 millions




LCTC Capital Expenditures first quarter 2024 Y/Y Growth Comment
Lifeloc Technologies Inc in the first quarter 2024 achieved Capital Expenditures of $ 0.08 millions compare to Capital Expenditures recorded in same quarter a year ago.

According to the results reported in the first quarter 2024, Lifeloc Technologies Inc achieved the best Capital Expenditures growth in Laboratory Analytical Instruments industry. While Lifeloc Technologies Inc ' s Capital Expenditures no change of % ranks overall at the positon no. in the first quarter 2024.


LCTC Capital Expenditures ( Y/Y Growth %) 2024
 2023 2022 2021
4th Quarter December - - -90 % 900 %
3rd Quarter September - -93.75 % 1500 % -
2nd Quarter June - -66.67 % -50 % -
1st Quarter March - - - -
FY   - -90.91 % -18.52 % 440 %

Financial Statements
Lifeloc Technologies Inc 's first quarter 2024 Capital Expenditures $ 0.08 millions LCTC's Income Statement
Lifeloc Technologies Inc 's first quarter 2023 Capital Expenditures $ 0.00 millions Quarterly LCTC's Income Statement


LCTC Capital Expenditures (Quarter on Quarter Growth %)

 2024
 2023 2022 2021
4th Quarter December - - -87.5 % 1900 %
3rd Quarter September - 0 % 433.33 % -83.33 %
2nd Quarter June - - 200 % -
1st Quarter March - - -95 % -
FY (Year on Year)   - -90.91 % -18.52 % 440 %


Suppliers by LCTC Divisions >> Back to LCTC Growth rate Comparisons >>


Capital Expenditures first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #
Healthcare Sector #
Overall #

Capital Expenditures Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Capital Expenditures first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #
Healthcare Sector #
Overall #
Capital Expenditures Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Capital Expenditures by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Lifeloc Technologies Inc 's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


LCTC's I. Quarter Q/Q Capital Expenditures Comment


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #
Healthcare Sector #
Overall #
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #
Healthcare Sector #
Overall #
Capital Expenditures Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


LCTC's I. Quarter Q/Q Capital Expenditures Comment


Lifeloc Technologies Inc 's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Mar 31 2024)		 12 Months Ending
(Dec 31 2023)		 12 Months Ending
(Sep 30 2023)		 12 Months Ending
(Jun 30 2023)		 12 Months Ending
(Mar 31 2023)
Cumulative Capital Expenditures 12 Months Ending $ 0.00 $ 0.00 $ 0.04 $ 0.20 $ 0.21
Y / Y Capital Expenditures Growth (TTM) - - -89.68 % -21.03 % -23.67 %
Year on Year Capital Expenditures Growth Overall Ranking # 1738 # 1435 # 1272 # 1149 # 1475
Seqeuential Capital Expenditures Change (TTM) - - -78.77 % -7.1 % -4.22 %
Seq. Capital Expenditures Growth (TTM) Overall Ranking # 1342 # 1647 # 249 # 1024 # 1247


Cumulative Capital Expenditures growth Comment
Lifeloc Technologies Inc realized trailing twelve months Capital Expenditures of $ 0 millions, in the Mar 31 2024, compare to Capital Expenditures of $ 0 millions a year ago.

In the Healthcare sector 217 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Capital Expenditures growth total ranking has deteriorated compare to previous quarter from 1435 to 1738.

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 5
Healthcare Sector # 218
Overall # 1738

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
449.94 %
 73.65 %
-89.68 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 5
Sector # 169
S&P 500 # 1342
Cumulative Capital Expenditures growth Comment
Lifeloc Technologies Inc realized trailing twelve months Capital Expenditures of $ 0 millions, in the Mar 31 2024, compare to Capital Expenditures of $ 0 millions a year ago.

In the Healthcare sector 217 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Capital Expenditures growth total ranking has deteriorated compare to previous quarter from 1435 to 1738.


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 5
Healthcare Sector # 218
Overall # 1738

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
449.94 %
73.65 %
-89.68 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 5
Sector # 169
S&P 500 # 1342




Other Capital Expenditures Growth
Laboratory Analytical Instruments Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
LCTC's Capital Expenditures Growth Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for LCTC's Competitors
Capital Expenditures Growth for Lifeloc Technologies Inc 's Suppliers
Capital Expenditures Growth for LCTC's Customers

You may also want to know
LCTC's Annual Growth Rates LCTC's Profitability Ratios LCTC's Asset Turnover Ratio LCTC's Dividend Growth
LCTC's Roe LCTC's Valuation Ratios LCTC's Financial Strength Ratios LCTC's Dividend Payout Ratio
LCTC's Roa LCTC's Inventory Turnover Ratio LCTC's Growth Rates LCTC's Dividend Comparisons



Companies with similar Capital Expenditures no change for the quarter ending Mar 31 2024 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Mar 31 2024
Adapthealth Corp -1.38%$ -1.379 millions
Prokidney Corp -2.64%$ -2.637 millions
Gilead Sciences Inc -3.67%$ -3.670 millions
Jasper Therapeutics Inc-3.85%$ -3.846 millions
Merit Medical Systems Inc-3.93%$ -3.929 millions
Owens and Minor inc-4.04%$ -4.044 millions
Genedx Holdings Corp -4.11%$ -4.113 millions
Beyond Air Inc -4.50%$ -4.500 millions
Biora Therapeutics Inc -6.25%$ -6.250 millions
Nautilus Biotechnology Inc -6.50%$ -6.503 millions
Hca Healthcare Inc -6.60%$ -6.600 millions
Alnylam Pharmaceuticals Inc -6.61%$ -6.609 millions
Amicus Therapeutics inc -6.75%$ -6.746 millions
Radnet Inc -7.05%$ -7.047 millions
Relay Therapeutics Inc -7.05%$ -7.050 millions
Sight Sciences Inc -7.14%$ -7.143 millions
Amphastar Pharmaceuticals Inc -7.22%$ -7.217 millions
United Therapeutics Corporation-7.51%$ -7.506 millions
Guardant Health Inc -7.84%$ -7.842 millions
Orthofix Medical Inc -8.60%$ -8.602 millions
National Healthcare Corp-10.32%$ -10.316 millions
Tenaya Therapeutics Inc -10.33%$ -10.334 millions
Brookdale Senior Living Inc -10.67%$ -10.666 millions
U S Physical Therapy Inc-10.73%$ -10.733 millions
Teva Pharmaceutical Industries Limited-10.79%$ -10.791 millions
Supernus Pharmaceuticals inc -10.79%$ -10.791 millions
Select Medical Holdings Corp-10.81%$ -10.814 millions
Keros Therapeutics Inc -10.92%$ -10.923 millions
Repligen Corp-11.24%$ -11.237 millions
Iqvia Holdings Inc -11.59%$ -11.585 millions


Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com